市場調查報告書
商品編碼
1542915
全球美國醫用黏合劑和密封劑市場 - 2024-2031U.S. Medical Adhesives and Sealants Market - 2024-2031 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
報告概述
美國醫用黏合劑和密封劑市場在2023年達到44.3億美元,預計到2031年將達到72.9億美元,在2024-2031年預測期間複合年成長率為6.6%。
醫用黏合劑和密封劑是外科手術過程中常用於黏合應用的化學製劑。它們由多種製造材料組成,由適合皮膚和海豹的合成和天然配方組成。
由於其非侵入性和成本效益等優點,它們成為外科手術的理想選擇。
驅動程式和限制
外科手術數量不斷增加
外科手術數量的增加以及該產品在心血管、牙科手術等各種外科手術中的使用量不斷增加是推動市場成長的主要因素之一。這是因為它們的使用被證明具有積極的手術效果,例如減少併發症、減少失血和縮短止血時間。
例如,根據 DMC Org 的出版物。據估計,美國每年約有50萬人接受心臟直視手術以矯正各種心血管疾病。
此外,根據美國整形外科醫生協會 2022 年的報告,2022 年大約進行了 576,485 例手術。
監管挑戰
醫用黏合劑和密封劑的嚴格法規和核准程序可能會限制產品進入市場。監管機構對安全性、有效性和生物相容性制定了嚴格的標準,以確保醫用黏合劑和密封劑不會對患者健康構成風險。
Report Overview
The U.S. medical adhesives and sealants market reached US$ 4.43 billion in 2023 and is expected to reach US$ 7.29 billion by 2031, growing at a CAGR of 6.6% during the forecast period 2024-2031.
Medical adhesives and sealants are chemical formulations commonly used for bonding applications during surgical procedures. They comprise a wide range of fabrication materials and are composed of synthetic and natural formulations suitable for skin and seals.
They became the ideal choice for surgical procedures owing to advantages offered by them such as non-invasiveness and cost-effectiveness.
Market Dynamics: Drivers & Restraints
Rising number of surgical procedures
The rising number of surgical procedures along with the growing usage of the product in various surgical procedures such as cardiovascular, dental surgeries, and others is one of the major factors boosting the market growth. It is because their usage is proven to have positive surgical outcomes such as reduced complications, reduced blood loss, and improved time to hemostasis.
For instance, according to the publication by DMC Org. it is estimated that approximately 500,000 people undergo open-heart surgery each year in the United States to correct various cardiovascular diseases.
Additionally, according to the report by the American Society of Plastic Surgeons in 2022 it is stated that around 576,485 procedures were performed in 2022. Thus, the increasing number of surgical procedures are expected to drive market growth in the region.
Regulatory Challenges
Stringent regulations and approval processes for medical adhesives and sealants could restrict the products from entering the market. Regulatory agencies impose stringent standards for safety, efficacy, and biocompatibility to ensure that medical adhesives and sealants do not pose risks to patient health.
The U.S. medical adhesives and sealants market is segmented based on type, application, end-users and region.
Natural segment is expected to dominate the market growth
The natural medical adhesives and sealants segment is expected to hold a dominant position during the forecast period. The products include fibrin, albumin, collagen, and others. Among all these, collagen is the most commonly used natural medical adhesive and sealant due to its excellent bond strength, elasticity, and biocompatibility. Also, it is a protein constituent in the animal connective tissue and has excellent adhesive properties.
Natural adhesives and sealants are often chosen in medical applications because they are made from natural sources such as proteins, peptides, and polysaccharides. These materials are naturally biocompatible, indicating that they are less likely to cause harm when in contact with body tissues or fluids. Natural adhesives and sealants have a smaller environmental impact than their synthetic equivalents because they are made from renewable resources and are biodegradable.
Synthetic
Acrylic
Silicones
Cyanoacrylate
Polyethylene Glycol
Others
Natural
Collagen
Fibrin
Albumin
Others
Dental Applications
Internal
Bone
Cardiovascular
Abdominal
Others
External
Tissue Bonding
Prosthesis Bonding
Others
Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)
Research and Academic Institutions
Others
The major players in the market include 3M Company, Baxter International Inc., Berry Plastics Corporation, Medtronic Plc, DENTSPLY International Inc., Johnson & Johnson, DuPont and Master Bond Inc. among others.
On January 11, 2023, H.B. Fuller launched Swiftmelt 1515-I, its first bio-compatible product compliant in IMEA - India, the Middle East, and Africa. The product is for medical tape applications to be used in stick-to-skin under unique climatic conditions, such as the high temperatures and humidity in the Indian sub-continent.
On February 1, 2024, Henkel introduced next-generation instant adhesives for medical device applications. The new products are formulated without CMR (Carcinogenic, Mutagenic or Reproductively hazardous) ingredients and are designed to offer increased strength during and after heat cycling.
To visualize the U.S. medical adhesives and sealants market segmentation based on type, application, end-users and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of medical adhesives and sealants market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.
The U.S. medical adhesives and sealants market report would provide approximately 53 tables, 47 figures and 176 pages.
Target Audience 2024
Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies